Evidence, Pricing and Access is Europe’s largest congress in market access, pricing and evidence featuring 150 speakers, multiple streams and over 1000 attendees from pharma, biotech and Payers/HTA’ s.
The 2021 edition will now take place over three days with expanded content on RWE, HTA, Affordability, Patient Advocacy and Emerging Markets.
We will also be strengthening our core topic areas which include, Market Access and Pricing, Rare Diseases, HTA/Payer and Evidence by covering the latest trends in reimbursement, payment models, Affordability, HEOR and many other developments within the industry.
We’re proud to be already working with a number of solution providers regarding sponsorship for this year’s event. A world leading forum which gives you the opportunity to showcase your solutions and thought leadership to key stakeholders across pharma and biotech.
Our vision is to create the world’s leading pricing, evidence, and market access congress in healthcare.
Evidence, Pricing and Access unites leading stakeholders from across the entire life science industry eco-system to create insight and to promote collaboration amongst pharma/biotech, HTAs, payers, patients, and solution providers.
We guarantee to give you an experience that is engaging, collaborative and global.